Filter
432
Text search:
test
positivity
rate
Featured
Recommendations
48
New Publications
138
Language
Document type
No document type
275
Guidelines
64
Studies & Reports
57
Manuals
12
Strategic & Response Plan
9
Fact sheets
6
Training Material
3
Situation Updates
3
Resource Platforms
3
Countries / Regions
India
44
Ethiopia
18
Uganda
12
Rwanda
12
Western and Central Europe
11
Global
11
Nigeria
10
Kenya
10
South Africa
10
Bangladesh
10
Myanmar / Burma
10
Africa
9
Malawi
8
Zimbabwe
7
Eastern Europe
7
South–East Asia Region
6
Ghana
5
Syria
5
Mozambique
5
East and Southern Africa
5
West and Central Africa
5
Burkina Faso
4
Philippines
4
Tanzania
4
Cambodia
4
Brazil
4
Liberia
3
Congo, Democratic Republic of
3
Nepal
3
Indonesia
3
Namibia
3
Botswana
3
Lesotho
3
Middle East and North Africa
3
Russia
3
Haiti
2
South Sudan
2
Lebanon
2
Zambia
2
Ukraine
2
Colombia
2
Yemen
2
Latin America and the Carribbean
2
Albania
2
Sierra Leone
1
Senegal
1
USA
1
Cameroon
1
Somalia
1
Pakistan
1
Afghanistan
1
Germany
1
Turkey
1
Sudan
1
Argentina
1
Eswatini/ Swaziland
1
Angola
1
Madagascar
1
Sri Lanka
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Paraguay
1
Asia
1
Venezuela
1
Poland
1
Palestine
1
Tajikistan
1
Vietnam
1
France
1
United Kingdom
1
Portugal
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
219
Clinical Guidelines
58
Pharmacy & Technologies
14
Public Health
11
Capacity Building
4
Women & Child Health
4
Key Resources
1
Toolboxes
TB
72
COVID-19
59
HIV
45
Rapid Response
17
NTDs
17
AMR
6
Disability
3
Ebola
3
Cholera
3
Refugee
3
Mental Health
3
Caregiver
3
NCDs
3
Polio
2
Conflict
2
Zika
2
Planetary Health
1
Antimalarial drug resistance has emerged as a threat to global malaria control efforts, particularly in the Greater Mekong subregion. Drawing on data collected through more than 1000 therapeutic efficacy studies as well as molecular marker studies of Plasmodium falciparum drug resistance, the Report
...
The purpose of this guide is to offer recommendations for improving the implementation of non‑pharmacological public health measures during the COVID-19 response and compliance with these measures by population groups in situations of vulnerability. This requires determining the main barriers to i
...
This FY 2018 Malaria Operational Plan (MOP) presents a detailed implementation plan for Ethiopia, based on the strategies of PMI and the National Malaria Control Program (NMCP). It was developed in consultation with the Federal Ministry of Health (FMOH), NMCP, Ethiopian Public Health Institute (EP
...
Interim Framework for the South-East Asia Region 28 October 2020
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) how virulent the variant is compared to other varian
...
The WHO End TB Strategy aims to end the global TB epidemic by 2030, in alignment with Goal 3 of the United Nations (UN) Sustainable Development Goals (SDGs). Member States of the World Health Organization (WHO) and the UN committed to ending the TB epidemic through adoption of WHO’s End TB Strateg
...
The objective of Health in the Americas: Overview of the Region of the Americas in the Context of the COVID-19 Pandemic is to respond to the need to address important public health issues in an increasingly timely manner, while serving as a platform with a close focus on specific issues of regional
...
The World Health Organization (WHO) convened a meeting of the Technical Advisory Group on Buruli ulcer at its headquarters in Geneva, Switzerland on 25 to 27 March 2019
The document explains why vector control is important in national programmes and describes the preparation of a tailor-made vector control plan for national programmes. It outlines entomological procedures for regular and specific vector control and how data should be analysed for better overall und
...
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr
...
The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.
The key actions, activities, and approaches in this document are organized within each of the 5Cs (see Table 1 in the PDF) and those of the Strategic preparedness and response plan (SPRP) pillars as follows:
National action plan key activities, prioritized for the current context and the current
...
PEPFAR Malawi’s Country Operational Plan (COP) 2021 reflects a culmination of strong interagency collaboration between the PEPFAR Malawi team, Government of Malawi (GoM), and civil society organizations (CSOs) to mitigate the devastating impacts of COVID-19 and sustain progress achieved over the l
...
Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde
...
Guidelines for the Prevention of Tuberculosis in Health Care Facilities in Resource-limited Settings
These guidelines are designed for settings with limited resources to provide inexpensive and effective control strategies for prevention of TB transmission in health care workers (HCW).
The aim of the people-centred framework is to help countries to develop fully prioritized and budgeted NSPs based on a culture of making full use of the available data, which are aligned with national planning cycles and which provide the basis for a robust national response that can accelerate prog
...
